Lipocine Inc. 4
4 · Lipocine Inc. · Filed Dec 8, 2016
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Mattila Jyrki
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-12-07$3.61/sh+40,000$144,400→ 40,000 totalExercise: $3.61From: 2017-12-07Exp: 2026-12-07→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years.